Login / Signup
PASI 100 response to secukinumab in primary failure to ustekinumab: analysis of cost-effectiveness among biological drugs.
Maria de Fátima P de Oliveira
Bruno de Oliveira Rocha
Gleison V Duarte
Published in:
International journal of dermatology (2021)
Keyphrases
</>
ankylosing spondylitis
rheumatoid arthritis
systemic lupus erythematosus
disease activity